---
schema_version: "secwatch.filing_event.v1"
accession: "0000805928-23-000049"
form_type: "8-K"
ticker: "AXGN"
cik: "0000805928"
company_name: "Axogen, Inc."
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T11:06:31.629543+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Axogen Q1 revenue up 18% to $36.7M; net loss narrows; FDA clears Axoguard HA+

## Summary
- Net revenue $36.7M (+18% YoY); net loss $7.1M vs $11.5M prior year.
- Adjusted net loss $4.1M ($0.10/share) vs $8.5M ($0.20/share) prior year.
- FDA 510(k) clearance for Axoguard HA+ Nerve Protector; pilot launch Q2, full launch Q3.
- Full-year 2023 revenue guidance reaffirmed at $154M-$159M.
- Cash and investments $44.1M at March 31, down from $55.0M at Dec 31, 2022.

## SEC filing metadata
- accession: 0000805928-23-000049
- form_type: 8-K
- ticker: AXGN
- cik: 0000805928
- company_name: Axogen, Inc.
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/805928/000080592823000049/0000805928-23-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/805928/000080592823000049/axgn-20230509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000805928-23-000049
- JSON: https://secwatch.observer/filing/0000805928-23-000049.json
- Plain text: https://secwatch.observer/filing/0000805928-23-000049.txt

## Key facts
- Earnings Releases
  Axogen, Inc. reported first quarter ended March 31, 2023 results: revenue $36.7 million, net income $7.1 million, EPS $0.17 per share. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2023
  - Revenue: $36.7 million
  - Net income: $7.1 million
  - EPS: $0.17 per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: today reported financial results and business highlights for the first quarter ended March 31, 2023. First Quarter Financial Results and Business Highlights • Net revenue was $36.7 million, an increase of 18% over the first quarter of 2022. • Gross margin was 81.7%, compared to 82.1% in the first quarter of 2022. • Net loss of $7.1 million, or $0.17 per share,
  evidence_url: https://www.sec.gov/Archives/edgar/data/805928/000080592823000049/0000805928-23-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.